Camurus AB (publ) (LON:0RD1)
London · Delayed Price · Currency is GBP · Price in SEK 593.50
-19.25 (-3.14%)
At close: Nov 5, 2025
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 2.81 billion as of November 5, 2025. Its market cap has increased by 1.46% in one year.
Market Cap
2.81B
Enterprise Value
2.55B
Revenue
173.97M
Ranking
n/a
PE Ratio
50.95
Stock Price
593.50
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 129.69M to 2.81B, an increase of 2,066.18%. That is a compound annual growth rate of 36.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 2.92B | 21.14% |
| Dec 30, 2024 | 2.41B | 3.42% |
| Dec 29, 2023 | 2.33B | 108.99% |
| Dec 30, 2022 | 1.11B | 64.59% |
| Dec 30, 2021 | 677.24M | -25.36% |
| Dec 30, 2020 | 907.38M | 154.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| GSK plc | 70.63B |
| Haleon | 31.88B |
| Smith & Nephew | 11.83B |
| ConvaTec Group | 4.74B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.68B |